Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • NVD vs GSK✓SelectedUSD · GSKNVD vs GSK performance historyLatest closeAs of+0.83%11/17
Stock and ETF performance explorer

NVD vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-98.4%
GSK return
+60.8%
Excess return
-159.2%
Maximum drawdown
-99.4%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D+0.8%-2.3%+3.2%+1.3%
7D+16.5%-3.0%+19.6%+17.3%
30D+76.6%+0.4%+76.3%+76.4%
3M+85.2%-1.2%+86.4%+85.4%
6M+68.4%+0.9%+67.5%+68.4%
YTD+1.5%+4.0%-2.5%0.0%
1Y-0.9%+7.3%-8.2%-2.8%
3Y-98.2%+57.1%-155.2%-98.2%
All-98.4%+60.8%-159.2%-98.5%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling